Identification of anti-SARS-CoV-2 agents based on flavor/fragrance compositions that inhibit the interaction between the virus receptor binding domain and human angiotensin converting enzyme 2

Identification of anti-SARS-CoV-2 agents based on flavor/fragrance compositions that inhibit the interaction between the virus receptor binding domain and human angiotensin converting enzyme 2

Show other versions (1)

Coronavirus disease 2019 (COVID-19) pandemic poses a threat to human beings and numerous cases of infection as well as millions of victims have been reported. The binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein receptor binding domain (RBD) to human angioten...

Full description

Bibliographic Details
Main Authors: Yasumitsu Nishimura, Kenta Nomiyama, Shuichiro Okamoto, Mika Igarashi, Yusuke Yorifuji, Yukino Sato, Ayasa Kamezaki, Aya Morihara, Futoshi Kuribayashi, Akira Yamauchi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762593/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762593/?tool=EBI

Similar Items